Bellerophon Therapeutics, Inc.
BLPHDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600132
Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Bellerophon Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 19 | 25 | +6 |
| Shares | 1.08M | 925.5K | −158.4K (−14.6%) |
| Value | $1.18M | $832.7K | −$349.3K (−29.5%) |
New holders (7)
Institutions that held Bellerophon Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 28,035 | $25.0K | 0.00% |
| Millennium Management LLC | 22,944 | $21.0K | 0.00% |
| Ergoteles LLC | 14,891 | $13.4K | 0.00% |
| Jane Street Group, LLC | 13,762 | $12.4K | 0.00% |
| NTV Asset Management LLC | 12,605 | $11.3K | 0.00% |
| UBS Group AG | 2,297 | $2.07K | 0.00% |
| Sofos Investments, Inc. | 1 | – | – |
Sold out (1)
Institutions that held Bellerophon Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 14,663 | $16.0K |